nodes	percent_of_prediction	percent_of_DWPC	metapath
Methimazole—CYP1A2—chronic obstructive pulmonary disease	0.352	1	CbGaD
Methimazole—CYP2A6—Arformoterol—chronic obstructive pulmonary disease	0.0693	0.127	CbGbCtD
Methimazole—CYP2A6—Formoterol—chronic obstructive pulmonary disease	0.0693	0.127	CbGbCtD
Methimazole—CYP2A6—Montelukast—chronic obstructive pulmonary disease	0.0526	0.0962	CbGbCtD
Methimazole—CYP2E1—Aminophylline—chronic obstructive pulmonary disease	0.0389	0.0712	CbGbCtD
Methimazole—CYP2A6—Prednisolone—chronic obstructive pulmonary disease	0.0308	0.0564	CbGbCtD
Methimazole—CYP2C19—Formoterol—chronic obstructive pulmonary disease	0.0287	0.0525	CbGbCtD
Methimazole—CYP2C19—Arformoterol—chronic obstructive pulmonary disease	0.0287	0.0525	CbGbCtD
Methimazole—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.0238	0.0436	CbGbCtD
Methimazole—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.0238	0.0436	CbGbCtD
Methimazole—CYP1A2—Aminophylline—chronic obstructive pulmonary disease	0.0225	0.0412	CbGbCtD
Methimazole—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.0218	0.0399	CbGbCtD
Methimazole—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.0218	0.0399	CbGbCtD
Methimazole—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.0194	0.0356	CbGbCtD
Methimazole—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0183	0.0335	CbGbCtD
Methimazole—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.0181	0.0331	CbGbCtD
Methimazole—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0124	0.0226	CbGbCtD
Methimazole—CYP2C19—Prednisone—chronic obstructive pulmonary disease	0.012	0.022	CbGbCtD
Methimazole—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0118	0.0216	CbGbCtD
Methimazole—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0105	0.0192	CbGbCtD
Methimazole—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.00617	0.0113	CbGbCtD
Methimazole—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.00582	0.0107	CbGbCtD
Methimazole—Epigastric distress—Salbutamol—chronic obstructive pulmonary disease	0.00283	0.0532	CcSEcCtD
Methimazole—Pigmentation skin—Prednisone—chronic obstructive pulmonary disease	0.0025	0.0471	CcSEcCtD
Methimazole—Pigmentation disorder—Prednisone—chronic obstructive pulmonary disease	0.00137	0.0258	CcSEcCtD
Methimazole—Lymphadenopathy—Salbutamol—chronic obstructive pulmonary disease	0.000933	0.0176	CcSEcCtD
Methimazole—Vertigo—Roflumilast—chronic obstructive pulmonary disease	0.000898	0.0169	CcSEcCtD
Methimazole—Myalgia—Roflumilast—chronic obstructive pulmonary disease	0.000851	0.016	CcSEcCtD
Methimazole—Neuritis—Prednisolone—chronic obstructive pulmonary disease	0.000842	0.0159	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Roflumilast—chronic obstructive pulmonary disease	0.000744	0.014	CcSEcCtD
Methimazole—Dyspepsia—Roflumilast—chronic obstructive pulmonary disease	0.000718	0.0135	CcSEcCtD
Methimazole—Alopecia—Aminophylline—chronic obstructive pulmonary disease	0.000677	0.0127	CcSEcCtD
Methimazole—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.000648	0.0122	CcSEcCtD
Methimazole—Drowsiness—Montelukast—chronic obstructive pulmonary disease	0.000636	0.012	CcSEcCtD
Methimazole—Neuropathy peripheral—Montelukast—chronic obstructive pulmonary disease	0.000624	0.0117	CcSEcCtD
Methimazole—Jaundice—Montelukast—chronic obstructive pulmonary disease	0.00062	0.0117	CcSEcCtD
Methimazole—Drowsiness—Salbutamol—chronic obstructive pulmonary disease	0.000613	0.0115	CcSEcCtD
Methimazole—Neuritis—Prednisone—chronic obstructive pulmonary disease	0.000612	0.0115	CcSEcCtD
Methimazole—Neuropathy peripheral—Salbutamol—chronic obstructive pulmonary disease	0.000601	0.0113	CcSEcCtD
Methimazole—Jaundice—Salbutamol—chronic obstructive pulmonary disease	0.000598	0.0113	CcSEcCtD
Methimazole—Hepatitis—Montelukast—chronic obstructive pulmonary disease	0.000571	0.0108	CcSEcCtD
Methimazole—Myalgia—Tiotropium—chronic obstructive pulmonary disease	0.000535	0.0101	CcSEcCtD
Methimazole—Arthralgia—Tiotropium—chronic obstructive pulmonary disease	0.000535	0.0101	CcSEcCtD
Methimazole—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.000519	0.00977	CcSEcCtD
Methimazole—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000515	0.00969	CcSEcCtD
Methimazole—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000514	0.00968	CcSEcCtD
Methimazole—Oedema—Tiotropium—chronic obstructive pulmonary disease	0.000513	0.00967	CcSEcCtD
Methimazole—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000511	0.00963	CcSEcCtD
Methimazole—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000485	0.00913	CcSEcCtD
Methimazole—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.000479	0.00902	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.000468	0.00881	CcSEcCtD
Methimazole—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.000461	0.00868	CcSEcCtD
Methimazole—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.000452	0.00851	CcSEcCtD
Methimazole—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000432	0.00814	CcSEcCtD
Methimazole—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.000432	0.00814	CcSEcCtD
Methimazole—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.000432	0.00814	CcSEcCtD
Methimazole—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.000432	0.00814	CcSEcCtD
Methimazole—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.000432	0.00814	CcSEcCtD
Methimazole—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.000431	0.00811	CcSEcCtD
Methimazole—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.00043	0.0081	CcSEcCtD
Methimazole—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.000423	0.00797	CcSEcCtD
Methimazole—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.000423	0.00797	CcSEcCtD
Methimazole—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000414	0.0078	CcSEcCtD
Methimazole—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000414	0.0078	CcSEcCtD
Methimazole—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000408	0.00768	CcSEcCtD
Methimazole—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000408	0.00768	CcSEcCtD
Methimazole—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000408	0.00768	CcSEcCtD
Methimazole—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000406	0.00764	CcSEcCtD
Methimazole—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000397	0.00748	CcSEcCtD
Methimazole—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000391	0.00737	CcSEcCtD
Methimazole—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000385	0.00725	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000377	0.00711	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000377	0.00711	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.00037	0.00696	CcSEcCtD
Methimazole—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000368	0.00693	CcSEcCtD
Methimazole—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000368	0.00693	CcSEcCtD
Methimazole—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000365	0.00687	CcSEcCtD
Methimazole—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000365	0.00687	CcSEcCtD
Methimazole—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000364	0.00686	CcSEcCtD
Methimazole—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000363	0.00684	CcSEcCtD
Methimazole—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000361	0.00679	CcSEcCtD
Methimazole—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000357	0.00673	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000356	0.00671	CcSEcCtD
Methimazole—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000351	0.00661	CcSEcCtD
Methimazole—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000348	0.00655	CcSEcCtD
Methimazole—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000346	0.00652	CcSEcCtD
Methimazole—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.000345	0.00649	CcSEcCtD
Methimazole—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000344	0.00648	CcSEcCtD
Methimazole—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000343	0.00646	CcSEcCtD
Methimazole—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000343	0.00646	CcSEcCtD
Methimazole—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000341	0.00642	CcSEcCtD
Methimazole—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000329	0.0062	CcSEcCtD
Methimazole—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000329	0.0062	CcSEcCtD
Methimazole—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000327	0.00617	CcSEcCtD
Methimazole—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000327	0.00617	CcSEcCtD
Methimazole—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000326	0.00615	CcSEcCtD
Methimazole—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000324	0.00609	CcSEcCtD
Methimazole—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000323	0.00609	CcSEcCtD
Methimazole—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000323	0.00609	CcSEcCtD
Methimazole—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000322	0.00607	CcSEcCtD
Methimazole—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000322	0.00606	CcSEcCtD
Methimazole—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000321	0.00604	CcSEcCtD
Methimazole—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000311	0.00585	CcSEcCtD
Methimazole—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000309	0.00582	CcSEcCtD
Methimazole—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000305	0.00574	CcSEcCtD
Methimazole—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000293	0.00552	CcSEcCtD
Methimazole—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000293	0.00552	CcSEcCtD
Methimazole—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000287	0.00541	CcSEcCtD
Methimazole—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000277	0.00521	CcSEcCtD
Methimazole—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000263	0.00496	CcSEcCtD
Methimazole—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000263	0.00496	CcSEcCtD
Methimazole—Rash—Formoterol—chronic obstructive pulmonary disease	0.000261	0.00492	CcSEcCtD
Methimazole—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000261	0.00492	CcSEcCtD
Methimazole—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000261	0.00491	CcSEcCtD
Methimazole—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000261	0.00491	CcSEcCtD
Methimazole—Headache—Formoterol—chronic obstructive pulmonary disease	0.000259	0.00489	CcSEcCtD
Methimazole—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000259	0.00489	CcSEcCtD
Methimazole—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000258	0.00486	CcSEcCtD
Methimazole—Rash—Montelukast—chronic obstructive pulmonary disease	0.000256	0.00482	CcSEcCtD
Methimazole—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000256	0.00481	CcSEcCtD
Methimazole—Headache—Montelukast—chronic obstructive pulmonary disease	0.000254	0.00479	CcSEcCtD
Methimazole—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	0.000251	0.00472	CcSEcCtD
Methimazole—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000249	0.00468	CcSEcCtD
Methimazole—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000247	0.00465	CcSEcCtD
Methimazole—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000247	0.00464	CcSEcCtD
Methimazole—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000246	0.00464	CcSEcCtD
Methimazole—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000246	0.00463	CcSEcCtD
Methimazole—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000246	0.00463	CcSEcCtD
Methimazole—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000245	0.00461	CcSEcCtD
Methimazole—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000241	0.00454	CcSEcCtD
Methimazole—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000232	0.00437	CcSEcCtD
Methimazole—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000224	0.00422	CcSEcCtD
Methimazole—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.000203	0.00382	CcSEcCtD
Methimazole—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000201	0.00379	CcSEcCtD
Methimazole—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000179	0.00338	CcSEcCtD
Methimazole—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000178	0.00336	CcSEcCtD
Methimazole—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.00017	0.0032	CcSEcCtD
Methimazole—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.00017	0.0032	CcSEcCtD
Methimazole—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000163	0.00307	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000149	0.0028	CcSEcCtD
Methimazole—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000146	0.00276	CcSEcCtD
Methimazole—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000143	0.0027	CcSEcCtD
Methimazole—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000141	0.00266	CcSEcCtD
Methimazole—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000141	0.00266	CcSEcCtD
Methimazole—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000141	0.00265	CcSEcCtD
Methimazole—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000133	0.00251	CcSEcCtD
Methimazole—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.00013	0.00244	CcSEcCtD
Methimazole—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000129	0.00243	CcSEcCtD
Methimazole—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000115	0.00217	CcSEcCtD
Methimazole—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000104	0.00195	CcSEcCtD
Methimazole—Rash—Prednisone—chronic obstructive pulmonary disease	0.000103	0.00194	CcSEcCtD
Methimazole—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000103	0.00193	CcSEcCtD
Methimazole—Headache—Prednisone—chronic obstructive pulmonary disease	0.000102	0.00192	CcSEcCtD
Methimazole—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000102	0.00209	CbGpPWpGaD
Methimazole—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000101	0.00208	CbGpPWpGaD
Methimazole—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000101	0.00207	CbGpPWpGaD
Methimazole—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	9.9e-05	0.00203	CbGpPWpGaD
Methimazole—CYP2C19—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	9.77e-05	0.00201	CbGpPWpGaD
Methimazole—Nausea—Prednisone—chronic obstructive pulmonary disease	9.68e-05	0.00182	CcSEcCtD
Methimazole—CYP2A6—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	9.63e-05	0.00198	CbGpPWpGaD
Methimazole—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—chronic obstructive pulmonary disease	9.54e-05	0.00196	CbGpPWpGaD
Methimazole—CYP1A2—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	9.54e-05	0.00196	CbGpPWpGaD
Methimazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—chronic obstructive pulmonary disease	9.54e-05	0.00196	CbGpPWpGaD
Methimazole—CYP1A2—Phase II conjugation—GSTT1—chronic obstructive pulmonary disease	9.41e-05	0.00193	CbGpPWpGaD
Methimazole—CYP2B6—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	9.35e-05	0.00192	CbGpPWpGaD
Methimazole—CYP1A2—Phase II conjugation—GCLC—chronic obstructive pulmonary disease	9.3e-05	0.00191	CbGpPWpGaD
Methimazole—CYP2A6—Fluoropyrimidine Activity—TP53—chronic obstructive pulmonary disease	9.28e-05	0.0019	CbGpPWpGaD
Methimazole—CYP2B6—Biological oxidations—GCLC—chronic obstructive pulmonary disease	9.24e-05	0.0019	CbGpPWpGaD
Methimazole—CYP2E1—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	9.15e-05	0.00188	CbGpPWpGaD
Methimazole—CYP2A6—NRF2 pathway—GSTP1—chronic obstructive pulmonary disease	9.15e-05	0.00188	CbGpPWpGaD
Methimazole—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	9.11e-05	0.00187	CbGpPWpGaD
Methimazole—CYP2E1—Biological oxidations—GCLC—chronic obstructive pulmonary disease	9.05e-05	0.00186	CbGpPWpGaD
Methimazole—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	9.03e-05	0.00185	CbGpPWpGaD
Methimazole—CYP2A6—NRF2 pathway—HMOX1—chronic obstructive pulmonary disease	9.03e-05	0.00185	CbGpPWpGaD
Methimazole—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	8.99e-05	0.00185	CbGpPWpGaD
Methimazole—CYP1A2—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	8.93e-05	0.00183	CbGpPWpGaD
Methimazole—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	8.91e-05	0.00183	CbGpPWpGaD
Methimazole—CYP2A6—NRF2 pathway—GSTM1—chronic obstructive pulmonary disease	8.41e-05	0.00173	CbGpPWpGaD
Methimazole—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	8.38e-05	0.00172	CbGpPWpGaD
Methimazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	8.2e-05	0.00168	CbGpPWpGaD
Methimazole—TPO—Metabolism—GSTT1—chronic obstructive pulmonary disease	8.17e-05	0.00168	CbGpPWpGaD
Methimazole—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	8.09e-05	0.00166	CbGpPWpGaD
Methimazole—TPO—Metabolism—GCLC—chronic obstructive pulmonary disease	8.07e-05	0.00166	CbGpPWpGaD
Methimazole—CYP2A6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	8.03e-05	0.00165	CbGpPWpGaD
Methimazole—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	8.03e-05	0.00165	CbGpPWpGaD
Methimazole—CYP2B6—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	7.77e-05	0.0016	CbGpPWpGaD
Methimazole—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	7.72e-05	0.00158	CbGpPWpGaD
Methimazole—CYP2B6—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	7.66e-05	0.00157	CbGpPWpGaD
Methimazole—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	7.62e-05	0.00156	CbGpPWpGaD
Methimazole—CYP2E1—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	7.61e-05	0.00156	CbGpPWpGaD
Methimazole—CYP2E1—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	7.5e-05	0.00154	CbGpPWpGaD
Methimazole—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	7.38e-05	0.00152	CbGpPWpGaD
Methimazole—CYP2A6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	7.38e-05	0.00152	CbGpPWpGaD
Methimazole—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	7.37e-05	0.00151	CbGpPWpGaD
Methimazole—TPO—Metabolism—CTGF—chronic obstructive pulmonary disease	7.37e-05	0.00151	CbGpPWpGaD
Methimazole—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	7.32e-05	0.0015	CbGpPWpGaD
Methimazole—CYP2C19—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	7.06e-05	0.00145	CbGpPWpGaD
Methimazole—CYP2A6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	6.99e-05	0.00144	CbGpPWpGaD
Methimazole—CYP2C19—Biological oxidations—GCLC—chronic obstructive pulmonary disease	6.98e-05	0.00143	CbGpPWpGaD
Methimazole—TPO—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.79e-05	0.00139	CbGpPWpGaD
Methimazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	6.64e-05	0.00136	CbGpPWpGaD
Methimazole—CYP1A2—Phase II conjugation—GSTP1—chronic obstructive pulmonary disease	6.52e-05	0.00134	CbGpPWpGaD
Methimazole—CYP2D6—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	6.5e-05	0.00133	CbGpPWpGaD
Methimazole—CYP2B6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	6.48e-05	0.00133	CbGpPWpGaD
Methimazole—CYP2C9—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	6.44e-05	0.00132	CbGpPWpGaD
Methimazole—CYP2D6—Biological oxidations—GCLC—chronic obstructive pulmonary disease	6.42e-05	0.00132	CbGpPWpGaD
Methimazole—CYP2B6—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	6.39e-05	0.00131	CbGpPWpGaD
Methimazole—CYP2C9—Biological oxidations—GCLC—chronic obstructive pulmonary disease	6.37e-05	0.00131	CbGpPWpGaD
Methimazole—CYP2E1—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	6.35e-05	0.0013	CbGpPWpGaD
Methimazole—CYP2E1—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	6.26e-05	0.00129	CbGpPWpGaD
Methimazole—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	6.26e-05	0.00128	CbGpPWpGaD
Methimazole—CYP1A2—Phase II conjugation—GSTM1—chronic obstructive pulmonary disease	5.99e-05	0.00123	CbGpPWpGaD
Methimazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	5.96e-05	0.00122	CbGpPWpGaD
Methimazole—CYP2B6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	5.95e-05	0.00122	CbGpPWpGaD
Methimazole—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	5.88e-05	0.00121	CbGpPWpGaD
Methimazole—CYP2B6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	5.87e-05	0.00121	CbGpPWpGaD
Methimazole—CYP2C19—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	5.87e-05	0.00121	CbGpPWpGaD
Methimazole—CYP2E1—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	5.83e-05	0.0012	CbGpPWpGaD
Methimazole—CYP2C19—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	5.79e-05	0.00119	CbGpPWpGaD
Methimazole—CYP2E1—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	5.75e-05	0.00118	CbGpPWpGaD
Methimazole—TPO—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.66e-05	0.00116	CbGpPWpGaD
Methimazole—CYP2B6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	5.64e-05	0.00116	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—APIP—chronic obstructive pulmonary disease	5.63e-05	0.00116	CbGpPWpGaD
Methimazole—TPO—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.58e-05	0.00115	CbGpPWpGaD
Methimazole—CYP2B6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	5.57e-05	0.00114	CbGpPWpGaD
Methimazole—CYP2E1—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	5.53e-05	0.00114	CbGpPWpGaD
Methimazole—CYP1A2—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	5.5e-05	0.00113	CbGpPWpGaD
Methimazole—CYP2E1—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	5.45e-05	0.00112	CbGpPWpGaD
Methimazole—CYP1A2—Biological oxidations—GCLC—chronic obstructive pulmonary disease	5.44e-05	0.00112	CbGpPWpGaD
Methimazole—CYP2D6—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	5.4e-05	0.00111	CbGpPWpGaD
Methimazole—CYP2C9—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	5.35e-05	0.0011	CbGpPWpGaD
Methimazole—CYP2D6—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	5.32e-05	0.00109	CbGpPWpGaD
Methimazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—chronic obstructive pulmonary disease	5.28e-05	0.00108	CbGpPWpGaD
Methimazole—CYP2C9—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	5.28e-05	0.00108	CbGpPWpGaD
Methimazole—TPO—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.2e-05	0.00107	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	4.96e-05	0.00102	CbGpPWpGaD
Methimazole—TPO—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.93e-05	0.00101	CbGpPWpGaD
Methimazole—CYP2C19—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	4.9e-05	0.00101	CbGpPWpGaD
Methimazole—CYP2C19—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	4.83e-05	0.000992	CbGpPWpGaD
Methimazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	4.83e-05	0.000992	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—APIP—chronic obstructive pulmonary disease	4.54e-05	0.000932	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	4.53e-05	0.00093	CbGpPWpGaD
Methimazole—CYP2D6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	4.5e-05	0.000925	CbGpPWpGaD
Methimazole—CYP2C19—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	4.5e-05	0.000924	CbGpPWpGaD
Methimazole—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	4.47e-05	0.000918	CbGpPWpGaD
Methimazole—CYP2C9—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	4.46e-05	0.000917	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—APIP—chronic obstructive pulmonary disease	4.45e-05	0.000913	CbGpPWpGaD
Methimazole—CYP2D6—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	4.44e-05	0.000912	CbGpPWpGaD
Methimazole—CYP2C19—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	4.44e-05	0.000911	CbGpPWpGaD
Methimazole—CYP2C9—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	4.4e-05	0.000904	CbGpPWpGaD
Methimazole—CYP2C19—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	4.26e-05	0.000876	CbGpPWpGaD
Methimazole—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	4.25e-05	0.000872	CbGpPWpGaD
Methimazole—CYP2C19—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	4.21e-05	0.000864	CbGpPWpGaD
Methimazole—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	4.2e-05	0.000862	CbGpPWpGaD
Methimazole—CYP2D6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	4.14e-05	0.00085	CbGpPWpGaD
Methimazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic obstructive pulmonary disease	4.1e-05	0.000843	CbGpPWpGaD
Methimazole—CYP2C9—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	4.1e-05	0.000842	CbGpPWpGaD
Methimazole—CYP2D6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	4.08e-05	0.000838	CbGpPWpGaD
Methimazole—CYP2C9—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	4.05e-05	0.000831	CbGpPWpGaD
Methimazole—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	4.02e-05	0.000826	CbGpPWpGaD
Methimazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—chronic obstructive pulmonary disease	4.02e-05	0.000826	CbGpPWpGaD
Methimazole—CYP2D6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.92e-05	0.000806	CbGpPWpGaD
Methimazole—CYP2C9—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.89e-05	0.000799	CbGpPWpGaD
Methimazole—CYP2D6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.87e-05	0.000795	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	3.87e-05	0.000794	CbGpPWpGaD
Methimazole—CYP2C9—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.84e-05	0.000788	CbGpPWpGaD
Methimazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	3.83e-05	0.000787	CbGpPWpGaD
Methimazole—CYP1A2—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	3.83e-05	0.000787	CbGpPWpGaD
Methimazole—CYP1A2—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	3.81e-05	0.000783	CbGpPWpGaD
Methimazole—CYP1A2—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.76e-05	0.000773	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.73e-05	0.000766	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—GC—chronic obstructive pulmonary disease	3.63e-05	0.000745	CbGpPWpGaD
Methimazole—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	3.53e-05	0.000725	CbGpPWpGaD
Methimazole—CYP1A2—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.51e-05	0.00072	CbGpPWpGaD
Methimazole—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	3.48e-05	0.000715	CbGpPWpGaD
Methimazole—CYP1A2—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.46e-05	0.00071	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—APIP—chronic obstructive pulmonary disease	3.43e-05	0.000705	CbGpPWpGaD
Methimazole—CYP2A6—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	3.43e-05	0.000704	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.37e-05	0.000692	CbGpPWpGaD
Methimazole—TPO—Metabolism—ALB—chronic obstructive pulmonary disease	3.35e-05	0.000688	CbGpPWpGaD
Methimazole—CYP1A2—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.32e-05	0.000682	CbGpPWpGaD
Methimazole—CYP1A2—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.28e-05	0.000673	CbGpPWpGaD
Methimazole—TPO—Metabolism—NOS3—chronic obstructive pulmonary disease	3.21e-05	0.000658	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—APIP—chronic obstructive pulmonary disease	3.16e-05	0.000648	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—APIP—chronic obstructive pulmonary disease	3.13e-05	0.000643	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.01e-05	0.000618	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.95e-05	0.000605	CbGpPWpGaD
Methimazole—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	2.94e-05	0.000605	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—GC—chronic obstructive pulmonary disease	2.93e-05	0.000601	CbGpPWpGaD
Methimazole—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	2.9e-05	0.000596	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—GC—chronic obstructive pulmonary disease	2.87e-05	0.000589	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.72e-05	0.000559	CbGpPWpGaD
Methimazole—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	2.71e-05	0.000556	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—APIP—chronic obstructive pulmonary disease	2.67e-05	0.000549	CbGpPWpGaD
Methimazole—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	2.67e-05	0.000548	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.66e-05	0.000547	CbGpPWpGaD
Methimazole—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	2.56e-05	0.000527	CbGpPWpGaD
Methimazole—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	2.53e-05	0.000519	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.45e-05	0.000502	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.27e-05	0.000467	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.25e-05	0.000463	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.23e-05	0.000458	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—GC—chronic obstructive pulmonary disease	2.21e-05	0.000454	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.09e-05	0.000429	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.07e-05	0.000426	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	2.06e-05	0.000424	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.06e-05	0.000422	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.06e-05	0.000422	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—GC—chronic obstructive pulmonary disease	2.03e-05	0.000418	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	2.02e-05	0.000414	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.98e-05	0.000407	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—GCLC—chronic obstructive pulmonary disease	1.96e-05	0.000402	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.91e-05	0.000391	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.89e-05	0.000388	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.87e-05	0.000385	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—CTGF—chronic obstructive pulmonary disease	1.79e-05	0.000367	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.77e-05	0.000364	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—GC—chronic obstructive pulmonary disease	1.72e-05	0.000354	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.65e-05	0.000338	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.64e-05	0.000336	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.6e-05	0.000329	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.6e-05	0.000328	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—GCLC—chronic obstructive pulmonary disease	1.58e-05	0.000324	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.57e-05	0.000322	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.55e-05	0.000318	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.49e-05	0.000307	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—CTGF—chronic obstructive pulmonary disease	1.44e-05	0.000296	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.41e-05	0.00029	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.37e-05	0.000282	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.37e-05	0.000281	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.35e-05	0.000278	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	1.33e-05	0.000273	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.33e-05	0.000273	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.3e-05	0.000267	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.28e-05	0.000262	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.26e-05	0.000259	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.24e-05	0.000254	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.21e-05	0.000248	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.2e-05	0.000246	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—GCLC—chronic obstructive pulmonary disease	1.19e-05	0.000245	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.11e-05	0.000229	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.11e-05	0.000228	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.11e-05	0.000228	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.1e-05	0.000226	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	1.1e-05	0.000226	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.09e-05	0.000224	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—CTGF—chronic obstructive pulmonary disease	1.09e-05	0.000224	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	1.09e-05	0.000224	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.09e-05	0.000223	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.07e-05	0.00022	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.02e-05	0.000209	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.02e-05	0.000208	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1e-05	0.000206	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	1e-05	0.000206	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—GSTM1—chronic obstructive pulmonary disease	9.97e-06	0.000205	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	9.93e-06	0.000204	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	9.65e-06	0.000198	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	9.45e-06	0.000194	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	9.41e-06	0.000193	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	9.3e-06	0.000191	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	9.23e-06	0.00019	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	9.15e-06	0.000188	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	8.67e-06	0.000178	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	8.49e-06	0.000174	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—GSTP1—chronic obstructive pulmonary disease	8.37e-06	0.000172	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.26e-06	0.00017	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—ALB—chronic obstructive pulmonary disease	8.13e-06	0.000167	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—NOS3—chronic obstructive pulmonary disease	7.78e-06	0.00016	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.7e-06	0.000158	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.69e-06	0.000158	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.63e-06	0.000157	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.59e-06	0.000156	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.53e-06	0.000155	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.29e-06	0.00015	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	7.26e-06	0.000149	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	7.18e-06	0.000147	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.08e-06	0.000145	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.02e-06	0.000144	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.71e-06	0.000138	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.65e-06	0.000137	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—ALB—chronic obstructive pulmonary disease	6.56e-06	0.000135	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	6.55e-06	0.000135	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.52e-06	0.000134	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.43e-06	0.000132	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—ALB—chronic obstructive pulmonary disease	6.43e-06	0.000132	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—NOS3—chronic obstructive pulmonary disease	6.28e-06	0.000129	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—NOS3—chronic obstructive pulmonary disease	6.15e-06	0.000126	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.04e-06	0.000124	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.99e-06	0.000123	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.68e-06	0.000117	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.03e-06	0.000103	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.97e-06	0.000102	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—ALB—chronic obstructive pulmonary disease	4.96e-06	0.000102	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—NOS3—chronic obstructive pulmonary disease	4.74e-06	9.74e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.63e-06	9.5e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	4.56e-06	9.36e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	4.52e-06	9.28e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.39e-06	9.01e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	4.36e-06	8.96e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	4.32e-06	8.88e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	3.86e-06	7.93e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	3.7e-06	7.59e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	2.98e-06	6.12e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	2.85e-06	5.86e-05	CbGpPWpGaD
